Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Receives Consensus Rating of "Moderate Buy" from Brokerages

Key Points

• Sabra Healthcare REIT, Inc. has received a consensus rating of "Moderate Buy" from seven analysts, with an average target price of $20.00.
• The company recently reported $0.38 EPS for the quarter, exceeding expectations of $0.36, and had a revenue of $189.15 million versus projected $185.64 million.
• Sabra Healthcare REIT declared a quarterly dividend of $0.30 per share, reflecting a yield of 6.2%, with a payout ratio of 157.89%.

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Get Free Report) has received an average rating of "Moderate Buy" from the seven analysts that are presently covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a hold recommendation, three have given a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $20.00.

Several equities research analysts have issued reports on SBRA shares. JMP Securities increased their target price on Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a "market outperform" rating in a research report on Wednesday, August 6th. Scotiabank raised their target price on Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a "sector perform" rating in a research note on Monday, June 23rd.

Sabra Healthcare REIT Stock Up 2.9%

Shares of NASDAQ:SBRA opened at $19.46 on Thursday. The company has a market capitalization of $4.67 billion, a price-to-earnings ratio of 25.61, a P/E/G ratio of 1.57 and a beta of 0.86. The company has a debt-to-equity ratio of 0.91, a current ratio of 4.80 and a quick ratio of 4.80. The business's 50-day moving average is $18.39 and its 200-day moving average is $17.65. Sabra Healthcare REIT has a 1 year low of $15.60 and a 1 year high of $20.03.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last issued its earnings results on Monday, August 4th. The real estate investment trust reported $0.38 EPS for the quarter, beating analysts' consensus estimates of $0.36 by $0.02. The business had revenue of $189.15 million during the quarter, compared to analyst estimates of $185.64 million. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.The firm's revenue was up 7.4% compared to the same quarter last year. During the same period in the previous year, the company posted $0.36 EPS. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. Equities research analysts predict that Sabra Healthcare REIT will post 1.45 earnings per share for the current year.

Sabra Healthcare REIT Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 29th. Investors of record on Friday, August 15th will be issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 6.2%. The ex-dividend date is Friday, August 15th. Sabra Healthcare REIT's payout ratio is presently 157.89%.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the company. Geode Capital Management LLC lifted its stake in Sabra Healthcare REIT by 0.8% in the 2nd quarter. Geode Capital Management LLC now owns 6,613,185 shares of the real estate investment trust's stock worth $121,960,000 after purchasing an additional 55,200 shares in the last quarter. Bank of New York Mellon Corp raised its position in Sabra Healthcare REIT by 1.5% in the 2nd quarter. Bank of New York Mellon Corp now owns 4,175,058 shares of the real estate investment trust's stock worth $76,988,000 after purchasing an additional 60,843 shares during the period. Northern Trust Corp raised its position in Sabra Healthcare REIT by 27.7% in the 4th quarter. Northern Trust Corp now owns 4,169,385 shares of the real estate investment trust's stock worth $72,214,000 after purchasing an additional 905,466 shares during the period. Nuveen LLC bought a new position in Sabra Healthcare REIT in the 1st quarter worth about $61,791,000. Finally, Janus Henderson Group PLC grew its stake in Sabra Healthcare REIT by 23.1% in the 4th quarter. Janus Henderson Group PLC now owns 3,504,809 shares of the real estate investment trust's stock worth $60,720,000 after acquiring an additional 657,950 shares in the last quarter. Institutional investors own 99.40% of the company's stock.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.